$3.21
-0.0319-0.98%
Last update: Nov 5, 4:00 PM

The average analyst price target for Molecular Partners is $9.58, 195.7% above the current price. Of 3 analysts, 2 rate it Buy and 1 Hold. Targets range from $3.75 to $13. The latest change came on Jan 27, 2026, when HC Wainwright & Co. initiated coverage of Molecular Partners with a Buy rating and a $13 price target.
Price Target Range — 6 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months